Mark For: EMISAR™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 90795780 |
Mark Literal Elements | EMISAR |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | SERVICE MARK |
Register | PRINCIPAL |
Current Location | TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED 2022-08-01 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Joseph V. Myers III |
2021-06-25 | Application Filed |
2021-06-29 | Location: NEW APPLICATION PROCESSING |
2021-06-29 | Status: Live/Pending |
2021-06-29 | Transaction Date |
2022-08-01 | Location: TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED |
2022-08-01 | Status: A non-final Office action has been sent (issued) to the applicant. This is a letter from the examining attorney requiring additi |
Party: | Emisar Pharma Services LLC |
Address | Corporation Trust Center, 1209 Orange St Wilmington, DELAWARE UNITED STATES 19801 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | DELAWARE |
Application | 2021-06-25 | |
Drawing | 2021-06-25 | |
Notation to File | 2022-04-06 | |
Offc Action Outgoing | 2022-04-06 | |
XSearch Search Summary | 2022-04-06 | |
XSearch Search Summary | 2022-04-06 | |
Response to Office Action | 2022-04-19 | |
Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2022-04-20 |
Non-Final Action | 2022-05-23 | |
Response to Office Action | 2022-06-30 | |
Amendment and Mail Process Complete | 2022-07-02 | |
Non-Final Action | 2022-08-01 | |
Notation to File | 2022-08-01 | |
Response to Office Action | 2022-11-03 |
IC 035. US 100 101 102. G & S: Business consulting and management services in the fields of prescription drugs and cost management of health care; Negotiating contracts with manufacturers of pharmaceuticals to obtain discounts on the purchase of their goods; Business consulting related to clinical trials; Pharmaceutical cost management services and drug utilization review services; Business administration of pharmacy reimbursement programs and services; Business research services, including providing analytics to facilitate pharmaceutical innovation; Providing a portal for pharmaceutical analytics, namely, providing a website featuring business information on pharmaceutical analytics
IC 036. US 100 101 102. G & S: Financial administration of pharmacy reimbursement programs and services
IC 042. US 100 101. G & S: Technological consulting and research in the field of pharmaceutical studies; Pharmaceutical product evaluation; Providing a portal for pharmaceutical analytics, namely, providing a website featuring medical research and scientific research information on pharmaceutical analytics
IC 044. US 100 101. G & S: Providing a portal for pharmaceutical analytics, namely, providing a website featuring medical information on pharmaceutical analytics
International Codes: | 35 |
U.S. Codes: | 100,101,102 |
International Codes: | 36 |
U.S. Codes: | 100,101,102 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0351 | Business consulting and management services in the fields of prescription drugs and cost management of health care; Negotiating contracts with manufacturers of pharmaceuticals to obtain discounts on the purchase of their goods; Business consulting related to clinical trials; Pharmaceutical cost management services and drug utilization review services; Administering pharmacy reimbursement programs and services; Business research and analytics services, including providing analytics to facilitate pharmaceutical innovation |
GS0361 | Financial administration of pharmacy reimbursement programs and services |
Description | Date | Proceeding Number |
---|---|---|
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-11-03 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-08-01 | |
NON-FINAL ACTION WRITTEN | 2022-08-01 | 94482 |
NON-FINAL ACTION E-MAILED | 2022-08-01 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-07-01 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-06-30 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-06-30 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-05-23 | |
NON-FINAL ACTION WRITTEN | 2022-05-23 | 94482 |
NON-FINAL ACTION E-MAILED | 2022-05-23 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-04-19 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-04-19 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-04-19 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-04-06 | 6325 |
NON-FINAL ACTION WRITTEN | 2022-04-06 | 94482 |
NON-FINAL ACTION E-MAILED | 2022-04-06 | 6325 |
ASSIGNED TO EXAMINER | 2022-03-16 | 94482 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-09-09 | |
NEW APPLICATION ENTERED IN TRAM | 2021-06-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.